AKT1 and cancer: DIM can affect mitogen-activated protein kinases (MAPKs), phosphoinositide 3-kinase (PI3K)/Akt and the NF-κB signaling pathway to play anti-cancer, anti-angiogenic and anti-inflammatory roles.